Closed vs. Open Abdomen Management for Sepsis
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Research suggests that using vacuum-assisted closure (VAC) for managing an open abdomen in septic patients can lead to faster abdominal closure and fewer complications compared to other methods. This implies that similar techniques in closed abdomen management might also be effective in improving outcomes for sepsis patients.
12345Temporary abdominal closure (TAC) is commonly used in cases of trauma and infection, and while it is generally safe, it can lead to complications such as the need for further abdominal wall reconstruction in some patients.
12567This treatment is unique because it compares two approaches: keeping the abdomen closed after surgery or leaving it open with a temporary closure using a special dressing. The open abdomen method allows for better management of infection and swelling, but it is controversial due to potential complications, while the closed method aims for quicker recovery by closing the abdomen sooner.
24589Eligibility Criteria
This trial is for adults with severe abdominal sepsis, indicated by specific scores like the World-Society-of-Emergency-Surgery-Sepsis-Severity Score >8. It's not for pregnant individuals, those with high intra-abdominal pressure (IAP>20 mmHg), patients without plans for continued care, cases of pancreatitis-induced peritonitis, or uncontrolled bleeding.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either closed or open abdomen management with ANPPT dressing after laparotomy for severe intra-abdominal infection
Follow-up
Participants are monitored for survival, blood IL-6 levels, and ICU stay duration
Post-operative Care
Formal abdominal closure or dressing change at 24-72 hours from placement
Participant Groups
Closed Abdomen Management is already approved in European Union, United States for the following indications:
- Abdominal sepsis
- Intra-abdominal infection
- Abdominal sepsis
- Intra-abdominal infection